Since that time, the FDA has acknowledged that advances in technology have expanded the use and capabilities of electronic systems in clinical investigations and have issued several guidance ...
Little is known about clinical trial investigator perspectives. To our knowledge, there are no published studies assessing differences in investigator perspectives on the basis of their primary role ...
Objective clinical responses by standard response criteria observed in Phase 1 dose escalation trial for FHD-286 in combination with decitabine in patients with relapsed and/or refractory AML; ...